Patanjali's plea for Ayurvedic medicine trials raises eyebrows

Media reports said the district Collector approved the proposal for clinical trial of some Ayurvedic medicines of the Patanjali group on COVID-19 patients but later quashed it. Patanjali Ayurved's MD Acharya Balkrishna told that there is a need to understand the company does not want to undertake any new experiment or trial of Ayurvedic treatment regime on COVID-19 patients in Indore.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3d9BAyj
via IFTTT